-
公开(公告)号:US20220392567A1
公开(公告)日:2022-12-08
申请号:US17804408
申请日:2022-05-27
Inventor: Sanjay Chawla , Ehsan Ullah , Raghvendra Mall , Hossam Almeer , Abdurrahman Elbasir
IPC: G16B15/30 , G16B40/20 , A61K31/438 , G06N20/20
Abstract: A global effort is underway to identify compounds to treat emerging virus infections, such as COVID-19. Since de novo compound design is an extremely long, time-consuming, and expensive process, efforts are underway to discover existing compounds that can be repurposed for COVID-19 and new viral diseases. The present invention discloses a machine learning representation framework that uses deep learning-induced vector embeddings of compounds and viral proteins as features to predict compound-viral protein activity. The prediction model uses a consensus framework to rank approved compounds against viral proteins of interest.